Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Salbutamol 2.5 mg Respule
Therapeutic Category
Pulmonary, Respiratory, Asthma
Dosage Form
Respule
Packaging Type
Pack
Packaging
8x5x2ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Salbutamol 2.5 mg Respule is a bronchodilator formulation used for inhalation therapy via nebulizer. It contains Salbutamol Sulphate equivalent to Salbutamol 2.5 mg, which acts on the β2-adrenergic receptors in the airway smooth muscles, leading to rapid bronchodilation. This helps relieve symptoms of bronchospasm, such as wheezing, shortness of breath, and chest tightness, commonly seen in asthma, chronic obstructive pulmonary disease (COPD), and other obstructive airway disorders.
Common side effects may include tremor, headache, palpitations, muscle cramps, and nervousness. Some patients may also experience tachycardia or mild throat irritation. Serious side effects are rare but should be reported to a healthcare provider promptly.
Indicated for the treatment and prevention of bronchospasm in patients with reversible obstructive airway diseases including asthma, bronchitis, emphysema, and COPD. It is especially beneficial in acute episodes of bronchoconstriction where rapid relief is needed.
Use only with a nebulizer device and under medical supervision. Avoid exceeding the prescribed dosage. Do not mix with other nebulizer solutions unless advised by a physician. Patients with cardiovascular disorders, hyperthyroidism, or diabetes should use it cautiously.
Store at room temperature (15-30°C), away from direct sunlight and moisture. Keep out of reach of children.
Composition : Lactulose 15 ml contains lactulose concentrate 66.7% in 6 gm Syrup
Composition : Ayurvedic Constipation Syrup
Composition : Aceclofenac (200mg) + Rabeprazole (20mg) Capsule
Composition : Acotiamide (100mg) Tablet
Composition : Acotiamide (300mg) Tablet
Composition : Magaldrate I.P. 400mg + Simethicone I.P. 20mg (Mango & Mint Flavour)
Composition : Magaldrate I.P. 480mg + Simethicone I.P. 20mg + Oxetacaine B.P. 10mg
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Salbutamol Respules have strong demand in the emergency respiratory and pulmonology segment, making them a fast-moving product for pharma distributors, wholesalers, and franchise partners. It is widely used for asthma attacks, wheezing, COPD exacerbations, and acute bronchospasm, ensuring consistent hospital and clinic-based demand.
Medical distributors and agencies benefit from the high-frequency use in emergency and acute respiratory conditions. Provides rapid bronchodilation and quick relief from breathlessness First-line therapy in asthma and acute wheezing episodes Commonly used in nebulization therapy in hospitals and clinics Widely prescribed by pulmonologists, emergency doctors, and general physicians Essential in ER, ICU, and pediatric respiratory care High demand during seasonal respiratory infections and pollution periods This makes it a fast-moving, essential emergency respiratory care product.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Salbutamol 2.5 mg Respules with monopoly rights, promotional support, quality manufacturing standards, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and franchise partners benefit from continuous emergency prescription demand, strong hospital and pulmonology usage, repeat acute episodes, and stable year-round turnover in the respiratory segment.
Interested distributors, stockists, and pharma franchise partners can contact Cafoli LifeCare Pvt Ltd to discuss monopoly territory rights, pricing structure, marketing support, and complete respiratory emergency product portfolio access to build a strong presence in the pulmonology and critical care market.